Evidence map›Paper›PMID 18594894›Full record

ArticleLipids2008

Anti-tumor effect of orally administered spinach glycolipid fraction on implanted cancer cells, colon-26, in mice.

Naoki Maeda, Yasuo Kokai, Seiji Ohtani, Hiroeki Sahara, Yuko Kumamoto-Yonezawa, Isoko Kuriyama, Takahiko Hada, Noriyuki Sato, Hiromi Yoshida, Yoshiyuki Mizushina

Abstract read
PubMed Publisher
In one paragraph

Article in Lipids, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Current drug discovery technologies · 2024
    Review
  3. Article
  4. Lipids Composition in Plant Membranes.Cell biochemistry and biophysics · 2020
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Naoki MaedaLaboratory of Food and Nutritional Sciences, Department of Nutritional Science, Kobe-Gakuin University, Kobe, Hyogo, 651-2180, Japan.
Yasuo Kokai
Seiji Ohtani
Hiroeki Sahara
Yuko Kumamoto-Yonezawa
Isoko Kuriyama
Takahiko Hada
Noriyuki Sato
Hiromi Yoshida
Yoshiyuki Mizushina
Kobe Gakuin University · JPSapporo Medical University · JPJapan Society for the Promotion of Science · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We succeeded in purifying a major glycolipid fraction from a green vegetable, spinach. This fraction consists mainly of three glycolipids: monogalactosyl diacylglycerol (MGDG), digalactosyl diacylglycerol (DGDG), and sulfoquinovosyl diacylglycerol (SQDG). In a previous study, we found that the glycolipid fraction inhibited DNA polymerase activity, cancer cell growth and tumor growth with subcutaneous injection. We aimed to clarify oral administration of the glycolipid fraction, suppressing colon adenocarcinoma (colon-26) tumor growth in mice. A tumor graft study showed that oral administration of 20 mg/kg glycolipid fraction for 2 weeks induced a 56.1% decrease in the solid tumor volume (P < 0.05) without any side-effects, such as loss of body weight or major organ failure, in mice. The glycolipid fraction induced the suppression of colon-26 tumor growth with inhibition of angiogenesis and the expression of cell proliferation marker proteins such as Ki-67, proliferating cell nuclear antigen (PCNA), and Cyclin E in the tumor tissue. These results suggest that the orally administered glycolipid fraction from spinach could suppress colon tumor growth in mice by inhibiting the activities of neovascularization and cancer cellular proliferation in tumor tissue.

Indexed as

Administration, OralAnimalsAntineoplastic AgentsCell Line, TumorCell ProliferationColonic NeoplasmsFemaleGlycolipidsHumansMiceMice, Inbred BALB CNeoplasm TransplantationSpinacia oleraceaAntineoplastic AgentsGlycolipids

Identifiers

PMID18594894
OpenAlexW2034405038

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.